Andere talen BiomX Inc.

Aandelen

PHGE

US09090D1037

Beurs gesloten - Nyse Andere beurzen 22:10:00 24-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,3399 ^USD	-1,90%		+21,35%	+21,39%

18/04	Biomx Inc. benoemt Susan Blum tot lid van de raad van bestuur en voorzitter van het auditcomité van de raad van bestuur	CI
03/04	Transcript : BiomX Inc., Q4 2023 Earnings Call, Apr 03, 2024

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases	24/04
BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024)	23/04
BiomX Announces the Appointment of Susan Blum to its Board of Directors	18/04
Biomx Inc. Appoints Susan Blum to Its Board of Directors and Member and Chair of the Audit Committee of the Board	18/04
BiomX : Introduction	04/04
BiomX Announces Compliance with NYSE Guidelines on Audit Opinion Disclosure	04/04
BiomX Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	03/04
BiomX Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03/04
BiomX to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast on April 3rd, 2024	27/03
Biomx Inc. Announces Board Changes	18/03
BiomX Announces Closing of the Acquisition of Adaptive Phage Therapeutics and Concurrent $50 Million Financing	18/03
BiomX Inc. announced that it has received $50.013969 million in funding from Deerfield Management Company, LLC, AMR Action Fund GP, LLC, Cystic Fibrosis Foundation, Nantahala Capital Management, LLC, OrbiMed Advisors LLC	15/03
BiomX Inc. completed the acquisition of Adaptive Phage Therapeutics, Inc.	15/03
Sector Update: Health Care Stocks Advance Wednesday Afternoon	06/03
Sector Update: Health Care	06/03
BiomX Shares Rally After Merger Deal With Adaptive Phage Therapeutics	06/03
BiomX : Material Agreement - Form 8-K	06/03
BiomX : Introduction	06/03
BiomX Announces Entry into Merger Agreement with Adaptive Phage Therapeutics and Concurrent $50 Million Financing	06/03
BiomX Inc. announced that it expects to receive $50.013969 million in funding from Deerfield Management Company, LLC, AMR Action Fund GP, LLC, Cystic Fibrosis Foundation, Nantahala Capital Management, LLC, OrbiMed Advisors LLC	06/03

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen BiomX Inc.

Aandelen

PHGE

US09090D1037

Andere talen

Filters